Bank Pictet & Cie (Europe)’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bank Pictet & Cie (Europe)’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.78M	Hold	23,871	–	–	0.07%	96
2026 Q1	$3.05M	Buy	23,871 +10,091	+73%	+$1.26M	0.07%	100
2025 Q4	$1.68M	Buy	+13,780	New	+$1.58M	0.03%	114
2025 Q1	–	Sell	-9,110	Closed	-$820K	–	204
2024 Q4	$820K	Buy	9,110 +2,040	+29%	+$198K	0.02%	116
2024 Q3	$699K	Hold	7,070	–	–	0.02%	113
2024 Q2	$655K	Hold	7,070	–	–	0.02%	112
2024 Q1	$671K	Buy	7,070 +1,540	+28%	+$143K	0.02%	118
2023 Q4	$494K	Buy	5,530 +1,680	+44%	+$125K	0.01%	184
2023 Q3	$281K	Hold	3,850	–	–	0.01%	224
2023 Q2	$320K	Hold	3,850	–	–	0.01%	216
2023 Q1	$293K	Sell	3,850 -124	-3%	-$10.3K	0.01%	152
2022 Q4	$330K	Hold	3,974	–	–	0.02%	140
2022 Q3	$315K	Hold	3,974	–	–	0.02%	138
2022 Q2	$295K	Hold	3,974	–	–	0.01%	135
2022 Q1	$357K	Sell	3,974 -15	-0.4%	-$1.39K	0.01%	138
2021 Q4	$447K	Sell	3,989 -91,085	-96%	-$11M	0.02%	136
2021 Q3	$12M	Sell	95,074 -7,896	-8%	-$1.02M	0.44%	46
2021 Q2	$13.9M	Sell	102,970 -6,420	-6%	-$844K	0.49%	46
2021 Q1	$14.8M	Buy	+109,390	New	+$16.4M	0.6%	43
2020 Q1	–	Sell	-12,000	Closed	-$1.14M	–	171
2019 Q4	$1.14M	Sell	12,000 -1,000	-8%	-$86.5K	0.17%	73
2019 Q3	$991K	Sell	13,000 -20,000	-61%	-$1.66M	0.17%	69
2019 Q2	$2.89M	Hold	33,000	–	–	0.5%	42
2019 Q1	$2.99M	Sell	33,000 -23,255	-41%	-$1.98M	0.51%	42
2018 Q4	$4.04M	Sell	56,255 -1,780	-3%	-$143K	0.82%	35
2018 Q3	$5.56M	Sell	58,035 -19,035	-25%	-$1.85M	0.78%	38
2018 Q2	$7.34M	Buy	77,070 +33,200	+76%	+$3.05M	1.13%	27
2018 Q1	$3.85M	Hold	43,870	–	–	0.64%	44
2017 Q4	$3.72M	Sell	43,870 -2,520	-5%	-$211K	0.53%	47
2017 Q3	$4.02M	Sell	46,390 -17,700	-28%	-$1.42M	0.58%	45
2017 Q2	$4.95M	Buy	64,090 +40,850	+176%	+$2.9M	0.7%	39
2017 Q1	$1.61M	Buy	+23,240	New	+$1.56M	0.23%	68

Other funds holding XBI

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

MIH

Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return

MSR

Main Street Research Lakeville, Connecticut $2.12B AUM 67.44% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

Whittier Trust South Pasadena, California $10.2B AUM 33.39% 1-Year Est. Return

Bank Pictet & Cie (Europe)'s XBI Position: Q2 2026 in Review

Bank Pictet & Cie (Europe) held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 23,871 shares worth $3.78M. The position accounts for 0.07% of the portfolio, ranked #96.

Bank Pictet & Cie (Europe) first reported a position in XBI in Q1 2017 and has held it in 31 quarters since. The position peaked at $14.8M in Q1 2021. 597 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Bank Pictet & Cie (Europe) held 23,871 shares of State Street SPDR S&P Biotech ETF worth $3.78M as of Q2 2026.
Bank Pictet & Cie (Europe) left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
State Street SPDR S&P Biotech ETF made up 0.07% of Bank Pictet & Cie (Europe)'s portfolio in Q2 2026, its #96 holding.
Bank Pictet & Cie (Europe) first reported a position in State Street SPDR S&P Biotech ETF in Q1 2017 and has held it in 31 quarters since.
Bank Pictet & Cie (Europe)'s State Street SPDR S&P Biotech ETF position peaked at $14.8M in Q1 2021.
597 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Bank Pictet & Cie (Europe)'s 13F filing for Q2 2026, filed 24 Jul 2026.